Dyne Therapeutics Inc (NQ: DYN )

12.81 +0.17 (+1.34%)

Streaming Delayed Price Updated: 12:09 PM EDT, May 31, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Dyne Therapeutics Inc

< Previous 1 2 Next >

Mid-Day Market Update: Nasdaq Tumbles 250 Points; Activision Blizzard Shares Jump

January 18, 2022

Midway through trading Tuesday, the Dow traded down 1.58% to 35,343.17 while the NASDAQ fell 1.70% to 14,640.00. The S&P also fell, dropping, 1.57% to 4,589.66. The U.S. has...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session

January 18, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device Designation for the treatment of chronic chemo induced...

Via Benzinga

FDA Issues Clinical Hold On Dyne's IND For Duchenne Muscular Dystrophy Program

January 18, 2022

The FDA has placed a clinical hold on Dyne Therapeutics Inc's (NASDAQ: DYN) investigational New Drug (IND) application to initiate a clinical trial of DYNE...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday

January 12, 2022

On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a...

Via Benzinga

Dyne Therapeutics Highlights New Preclinical Data For Duchenne Muscular Dystrophy Program

October 01, 2021

Dyne Therapeutics Inc (NASDAQ: DYN) has announced new data presented today during the 2021 Muscle Study Group Annual Scientific Meeting for its Duchenne muscular...

Via Benzinga

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout

June 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...

Via Benzinga

Stocks Hitting New 52-Week Lows Today

January 03, 2022

On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...

Via Benzinga

Dyne Therapeutics' Myotonic Dystrophy Gene Therapy Shows Encouraging Action In Animal Studies

May 14, 2021

Dyne Therapeutics Inc (NASDAQ: DYN) has announced new preclinical data from its myotonic dystrophy type 1 (DM1) program, including results demonstrating...

Via Benzinga

< Previous 1 2 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.